PET/CT scanning for breast cancer that has spread
Part of Cancer, Skin clinical trials.
This study compares two types of scans—one that uses a special tracer (PET/CT) and another that uses contrast dye (CT)—to see how well they find breast cancer that has spread to other parts of the body. It may help find the best way to spot distant metastases early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have breast cancer that has been confirmed by a biopsy or other tissue test.
- Your breast cancer must have spread to other parts of your body, confirmed by a scan or tissue sample.
- You must have both the PET/CT scan and the contrast CT scan within 1 to 3 weeks of each other.
- You must not have another type of cancer.
- You must not have had chemotherapy or radiation therapy between the two scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of scans (PET/CT and CT) to see which is better at monitoring metastatic breast cancer. If you are starting your first treatment for breast cancer that has spread to other parts of the body, this study may help determine the best way to track your disease.
This trial tests whether a special PET scan (FDG PET-CT) can better track how well treatment is working for people with advanced breast cancer. It may help doctors choose the best therapy and monitor response over time.
This trial studies how an FDG PET/CT scan (a special imaging test that looks for active cancer activity) can be used in people with high-risk primary or recurring breast cancer. It may help doctors better identify areas of concern and guide future care.
This study tests a new imaging technique using a special tracer (68Ga-DOTA-BLP) that may help spot cancer more accurately. It is for people with confirmed cancer who have suspicious lymph nodes or possible spread, and who have not yet started cancer treatment.
This trial is testing a special PET scan (18F-FES PET/CT) to see if it can find distant cancer spread in women with a slow-growing, estrogen receptor-positive, stage III breast cancer. The goal is to find out whether this imaging test can detect hidden metastases better than standard scans.
This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.
Hear when a new Breast Cancer (Locally Advanced or Metastatic) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.